Clinical Trial Update: CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating CD19-specific T-cell therapy for Chronic Lymphocytic Leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Leukemia

Drugs mentioned

• CD19-specific T-cell therapy

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers, Leukemia | Phase 1 | Status: COMPLETED